Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common stock, $0.0001 par value
-
Shares outstanding
-
49,883,741
-
Total 13F shares
-
2,171,190
-
Share change
-
+494,243
-
Total reported value
-
$10,009,408
-
Price per share
-
$4.61
-
Number of holders
-
31
-
Value change
-
+$2,041,090
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) as of Q3 2024
As of 30 Sep 2024 TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,171,190 shares of stock of the company.
Largest 10 holders included Wealthcare Advisory Partners LLC, Duquesne Family Office LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, MSD Partners, L.P., Exos Asset Management LLC, Lido Advisors, LLC, Connecticut Wealth Management, LLC, and BlackRock, Inc..
This table shows 31 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.